Terminated NA INTERVENTIONAL 18-arm NCT03972813

Optimizing HPV Vaccine Introduction in Shanghai, China

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Interventions Blank information about communicability Broadened information about cancers Cervical cancer Information about STDs Information about infectious disease Recommendation for children 12 years old Recommendation for children 18 years old Standard age information

Updated 10 times since 2019 Last updated: Jan 13, 2025 Started: May 28, 2019 Primary completion: Aug 31, 2019 Completion: Aug 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to COVID-19, we were unable to continue data collection in China.

Other terminated trials from National Institute of Allergy and Infectious Diseases (NIAID)

See all terminations from National Institute of Allergy and Infectious Diseases (NIAID)

This NA trial investigates Vaccine Refusal and is currently terminated or withdrawn. National Institute of Allergy and Infectious Diseases (NIAID) leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Feb 2025 — Present [monthly]

Terminated NA
Sep 2024 — Feb 2025 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
May 2023 — Jul 2024 [monthly]

Terminated NA
Apr 2023 — May 2023 [monthly]

Terminated NA

Status: Active Not Recruiting → Terminated

▶ Show 5 earlier versions

Feb 2022 — Apr 2023 [monthly]

Active Not Recruiting NA
Feb 2021 — Feb 2022 [monthly]

Active Not Recruiting NA
Jan 2021 — Feb 2021 [monthly]

Active Not Recruiting NA
Feb 2020 — Jan 2021 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jul 2019 — Feb 2020 [monthly]

Recruiting NA

First recorded

May 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Allergy and Infectious Diseases (NIAID)
Shanghai Municipal Center for Disease Control and Prevention
University of Michigan

Data source: University of Michigan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China